Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Hofs

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Anti-Cancer Drugs|April 1, 1997
The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activityH P Hofs, T D Wagener, V de Valk-Bakker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclonesH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Anticancer Research|January 1, 1992
Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemiaH P Hofs, D J Wagener, V De Valk-Bakker, et al.
Anti-Cancer Drugs|April 1, 1995
Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Investigational New Drugs|January 1, 1995
Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatinH P Hofs, D J Wagener, V De Valk-Bakker, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Anti-Cancer Drugs|April 1, 1997
The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activityH P Hofs, T D Wagener, V de Valk-Bakker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclonesH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Anticancer Research|January 1, 1992
Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemiaH P Hofs, D J Wagener, V De Valk-Bakker, et al.
Anti-Cancer Drugs|April 1, 1995
Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Investigational New Drugs|January 1, 1995
Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatinH P Hofs, D J Wagener, V De Valk-Bakker, et al.
Pageof 2